It's my prediction, it'll consolidate this levels and then head back up, possibly quickly.
Still plenty more news to come, this is just the beginning so when sentiment fully turns back positive like April, this will rocket.
https://www.gov.uk/drug-device-alerts/results-from-laboratory-based-tests-for-covid-19-antibodies-using-capillary-blood-sample-collection-kits-may-not-be-reliable-mda-2020-015
Strongly suggest people read this.
But based on the timing, i assume we might have another mention from the government in the daily briefing.
I'm also wondering if its not to do with that but finally the OEM US announcement, to conincide with the middle of the day trading over there.
I haven't been able to find the research that is apparently out there, but it is quite clear somebody knows something and that something is really good.
the beauty of numbers means it could be 40% tomorrow, 30% thursday and 20% friday and we'd end up in the same place.
I'm a little concerned we seem to be more closely correlated to markets at the moment (just with a higher overall beta), i'd hope we can snap out of that and if markets fall back again we keep on growing.
Today is just one day but i think the recovery is back on. Fill yer boots.
Surfie, i'd just suggest filtering his posts if you don't like it, then move on to talking about the stock again.
We're all after the same goal at the end of the day.
Good point DUFC23!
Tom Winnifrith's short to zero position is based on zero credible facts. The man has done no proper research on the company, knows nothing about the sector and has plucked figures out of thin air. If you followed him initially when he said short NCYT , which was at around 30-60p, you'd have lost a fortune, so by picking the april to now timescale is simply framing to suit your own argument.
Only time will tell who is right but I would suggest looking at his history and you'll see his success rate is incredibly low.
rival stocks are down 11%, 13%, 5% respectively... it appears the second wave fears have not had the bounce effect that was felt before. Nothing has changed here in terms of fundmentals, we just have to sit and wait for news on the exsig and mobile tests.
And the more research that is done, the more convinced I am that this is easily a £1bn + market cap company in the next 6 months.
But WHO are massively concerned about africa's lack of tests. Under the procurement agreement i feel it's only a matter of time before they dig into their pocks and buy a shed load more tests from us to supply africa.
June and July are going to be fantastic months for shareholders.
spot on, it really is as simple as that.
ODX: RNS down 6.6% roughly
AVCT: RNS down 7.6% roughly
Genedrive: no RNS but down over 10%
NCYT: UP over 3%
Today could be the day
lets hope its one way from here now the forward selling is potentially finished.
You'll just get very different treatment instead from the Cornish locals!
alamo55, orph;s news was good but when you read into it there are some key flaws, hence the rise has hardly been spectacular over there this morning.
last support level mentioned i think was 270, and if failing that it was expected to drop to 200 before recovering.
Sincerely hoping that isn't the case and i've topped up again at 250 already, but this is scary how badly the share has done this week against a backdrop of very very good news.
But as always, never trade in the first hour and hold for gold. My prediction of a re-rate yesterday was majorly wide of the mark; still hoping the market wakes up to the vastly undervalued stock here and rises into the day.
My two pence worth:
Fundamentals: 9/10
Sales as a proportion of market cap: 9/10
Future revenue streams: 9/10
Current share price vs likely future share price: 10/10
Demand for the share: 4/10
Communication from the business (marketing/ RNS): 4/10 (I'm being harsh and many will disagree but I strongly disliked the annual results RNS and felt today's RNS could've been worded better, the news was excellent and will reflect soon I hope but it has caused the drop still).
Deduct points for:
Too much expectation on the share, causing panic exits when news doesn't quite match or misses details
Priced in anticipation vs reality
Lack of clarity over the Egypt order
Lack of US sales (to this point)
Links to the big firms being understated or disproven (Thermofisher in the US)
No communication over licensing deals (if there are any)
Overall, still a strong buy at this price. I'm not ramping, I hold the share and want it to do well but I also understand that the users of this BB have very little sway on the overall share price movement and it doesn't actually matter what I say. I've held the share since February so have made enough profit many times over to buy sit and watch the next few months unfold, and don't see any other share having the potential this does at a fair level of risk.
went back to look at intraday goings on in mid april, before those massive rises the share price drifted down in the first hour's trading (as it always does) before rocketing into the end of the day.
Anyone trading this will have their pants pulled down at some stage IMO
Drop expected but will rise throughout the day.